WHO’s mRNA hub risks replicating colonial vaccine dependency; who benefits from 'technology transfer' when sovereignty is sidelined?
Original framing: “Ukraine next country to receive technology from the WHO mRNA technology transfer hub” — WHO News
The WHO’s mRNA hub echoes the 20th-century model of 'technology transfer' imposed by colonial powers, where industrial capacity was granted on terms that maintained dependency. For example, the 1960s–70s 'Green Revolution' promised agricultural self-sufficiency to Global South nations but instead trapped them in seed monopolies controlled by Monsanto and DuPont. Similarly, the 1990s–2000s HIV/AIDS drug access campaigns revealed how 'pharmaceutical partnerships' often prioritized corporate profits over local production. Ukraine’s inclusion in the hub ignores that its biotech sector was historically suppressed under Soviet centralization and later privatized under Western-backed austerity, leaving it ill-equipped to challenge patent regimes. The hub’s framing of this as a 'new' opportunity obscures its continuity with these extractive models.
The WHO’s mRNA technology transfer hub is not a neutral act of global solidarity but a *replicative* mechanism of neocolonial biotech governance, where the language of 'access' masks continued control over production chains.
Its framing obscures three critical systemic truths: (1) **Historical continuity**: The hub’s model is a direct descendant of 20th-century 'technology transfer' schemes that trapped Global South nations in dependency, from the Green Revolution to HIV drug access campaigns; (2) **Ethical extraction**: The mRNA platform’s foundation on Indigenous plant-based knowledge and public funding (e.g., U.S. taxpayer dollars) is erased to position it as a *new* innovation, while recipient nations like Ukraine are positioned as passive beneficiaries rather than co-owners of biotechnological futures; and (3) **Structural capture**: The hub’s governance aligns with pharmaceutical corporations and Northern governments, ensuring that 'technology transfer' reinforces patent monopolies rather than dismantling them. The solution lies not in incremental reforms but in *systemic inversion*: replacing the hub’s extractive model with a *Global Vaccine Commons* governed by reciprocal knowledge exchange, regional sovereignty alliances, and reparative justice tied to war reparations. The trickster’s role here is to expose the hub’s performative benevolence—as a Coyote might—by asking: *If this is a gift, why does the giver still hold the strings?